| Factor I is required for the development of membranoproliferative glomerulonephritis in factor H–deficient mice KL Rose, D Paixao-Cavalcante, J Fish, AP Manderson, TH Malik, ... The Journal of clinical investigation 118 (2), 608-618, 2008 | 174 | 2008 |
| The development of atypical hemolytic uremic syndrome depends on complement C5 EG de Jorge, P Macor, D Paixao-Cavalcante, KL Rose, F Tedesco, ... Journal of the American Society of Nephrology 22 (1), 137-145, 2011 | 135 | 2011 |
| Factor H autoantibodies in membranoproliferative glomerulonephritis THJ Goodship, IY Pappworth, T Toth, M Denton, K Houlberg, ... Molecular immunology 52 (3-4), 200-206, 2012 | 103 | 2012 |
| Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation D Paixao-Cavalcante, M Lopez-Trascasa, L Skattum, PC Giclas, ... Kidney international 82 (10), 1084-1092, 2012 | 101 | 2012 |
| Loxosceles sphingomyelinase induces complement-dependent dermonecrosis, neutrophil infiltration, and endogenous gelatinase expression DV Tambourgi, D Paixao-Cavalcante, RMG de Andrade, ... Journal of Investigative Dermatology 124 (4), 725-731, 2005 | 90 | 2005 |
| Molecular cloning, expression, function and immunoreactivities of members of a gene family of sphingomyelinases from Loxosceles venom glands DV Tambourgi, MFF Pedrosa, CW van den Berg, ... Molecular immunology 41 (8), 831-840, 2004 | 76 | 2004 |
| Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by Loxosceles venom sphingomyelinase D D Paixão-Cavalcante, CW Van den Berg, ... Journal of investigative dermatology 126 (1), 61-68, 2006 | 59 | 2006 |
| Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase D Paixão-Cavalcante, S Hanson, M Botto, HT Cook, MC Pickering Molecular immunology 46 (10), 1942-1950, 2009 | 56 | 2009 |
| Tetracycline protects against dermonecrosis induced by Loxosceles spider venom D Paixão-Cavalcante, CW van den Berg, RM Goncalves-de-Andrade, ... Journal of Investigative Dermatology 127 (6), 1410-1418, 2007 | 52 | 2007 |
| Decay-accelerating factor suppresses complement C3 activation and retards atherosclerosis in low-density lipoprotein receptor-deficient mice VWY Leung, S Yun, M Botto, JC Mason, TH Malik, W Song, ... The American journal of pathology 175 (4), 1757-1767, 2009 | 50 | 2009 |
| A humanized antibody that regulates the alternative pathway convertase: potential for therapy of renal disease associated with nephritic factors D Paixão-Cavalcante, E Torreira, MA Lindorfer, S Rodriguez de Cordoba, ... The Journal of Immunology 192 (10), 4844-4851, 2014 | 46 | 2014 |
| Duvernoy's gland secretion of Philodryas olfersii and Philodryas patagoniensis (Colubridae): neutralization of local and systemic effects by commercial bothropic antivenom … MMT Rocha, D Paixão-Cavalcante, DV Tambourgi, DF Maria de Fátima Toxicon 47 (1), 95-103, 2006 | 43 | 2006 |
| Nanostructured SBA-15 silica: An effective protective vehicle to oral hepatitis B vaccine immunization K Scaramuzzi, GD Tanaka, FM Neto, PRAF Garcia, JJM Gabrili, ... Nanomedicine: Nanotechnology, Biology and Medicine 12 (8), 2241-2250, 2016 | 34 | 2016 |
| African Adders: Partial Characterization of Snake Venoms from Three Bitis Species of Medical Importance and Their Neutralization by Experimental Equine … D Paixão-Cavalcante, AK Kuniyoshi, FCV Portaro, WD da Silva, ... PLoS neglected tropical diseases 9 (2), e0003419, 2015 | 28 | 2015 |
| Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice D Paixao-Cavalcante, M Botto, HT Cook, MC Pickering Clinical & Experimental Immunology 155 (2), 339-347, 2009 | 28 | 2009 |
| Kinetic and mechanistic characterization of the Sphingomyelinases D from Loxosceles intermedia spider venom SA De Andrade, MT Murakami, DP Cavalcante, RK Arni, DV Tambourgi Toxicon 47 (4), 380-386, 2006 | 28 | 2006 |
| Deficiency of the human complement regulatory protein factor H associated with low levels of component C9 DA Falcao, ES Reis, D Paixão‐Cavalcante, MT Amano, M Delcolli, ... Scandinavian journal of immunology 68 (4), 445-455, 2008 | 24 | 2008 |
| The development of atypical hemolytic uremic syndrome depends on complement C5 EG Jorge, P Macor, D Paixao-Cavalcante, KL Rose, F Tedesco, HT Cook, ... J Am Soc Nephrol 22, 137-145, 2011 | 9 | 2011 |
| C5 activation is required for the development of atypical haemolytic uraemic syndrome in Cfh−/−· FHΔ16–20 mice EG de Jorge, D Paixao-Cavalcante, KL Rose, HT Cook, M Botto, ... Molecular Immunology 45 (16), 4100-4101, 2008 | 8 | 2008 |
| Assessment of the neutralizing potency of ovine antivenom in a swiss mice model of Bothrops jararaca envenoming J Ferreira, MF Bastos, AC Pelizon, CM Peres, DP Cavalcante, A Sartori Journal of Venomous Animals and Toxins including Tropical Diseases 11, 336-349, 2005 | 5 | 2005 |
